148 related articles for article (PubMed ID: 16732158)
21. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Advisory Committee on Immunization Practices
MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
[TBL] [Abstract][Full Text] [Related]
22. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study.
Liese JG; Schoen C; van der Linden M; Lehmann L; Goettler D; Keller S; Maier A; Segerer F; Rose MA; Streng A
Clin Microbiol Infect; 2019 Jul; 25(7):857-864. PubMed ID: 30395932
[TBL] [Abstract][Full Text] [Related]
23. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Del Castillo F; Hernández-Sampelayo T; Bueno M; Calvo C; Ríos E; Méndez C;
Pediatr Infect Dis J; 2011 Jun; 30(6):471-4. PubMed ID: 21266938
[TBL] [Abstract][Full Text] [Related]
24. A multiplex polymerase chain reaction method for rapid pneumococcal serotype determination in childhood empyema.
Maataoui N; Bidet P; Doit C; De Lauzanne A; Lorrot M; Mariani-Kurkdjian P; Faye A; Bingen E
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):245-9. PubMed ID: 21353946
[TBL] [Abstract][Full Text] [Related]
25. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
[TBL] [Abstract][Full Text] [Related]
26. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
[TBL] [Abstract][Full Text] [Related]
27. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
Obando I; Camacho-Lovillo MS; Porras A; Gandía-González MA; Molinos A; Vazquez-Barba I; Morillo-Gutierrez B; Neth OW; Tarrago D
Clin Microbiol Infect; 2012 Aug; 18(8):763-8. PubMed ID: 21910779
[TBL] [Abstract][Full Text] [Related]
28. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
[TBL] [Abstract][Full Text] [Related]
29. Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.
Clarke SC; Jefferies JM; Smith AJ; McMenamin J; Mitchell TJ; Edwards GF
J Clin Microbiol; 2006 Apr; 44(4):1224-8. PubMed ID: 16597842
[TBL] [Abstract][Full Text] [Related]
30. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
[TBL] [Abstract][Full Text] [Related]
31. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
[TBL] [Abstract][Full Text] [Related]
33. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
[TBL] [Abstract][Full Text] [Related]
34. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
[TBL] [Abstract][Full Text] [Related]
35. New insights on pneumococcal disease: what we have learned over the past decade.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
[TBL] [Abstract][Full Text] [Related]
36. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the immune response to pneumococcal capsular polysaccharides.
Jeurissen A; Boudewijns M; Proesmans M; Ceuppens JL; De Boeck K; Bossuyt X
Acta Clin Belg; 2003; 58(2):106-10. PubMed ID: 12836493
[TBL] [Abstract][Full Text] [Related]
38. The increasing incidence of empyema.
Burgos J; Falcó V; Pahissa A
Curr Opin Pulm Med; 2013 Jul; 19(4):350-6. PubMed ID: 23508113
[TBL] [Abstract][Full Text] [Related]
39. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.
Balmer P; Borrow R; Findlow J; Warrington R; Frankland S; Waight P; George R; Andrews N; Miller E
Clin Vaccine Immunol; 2007 Nov; 14(11):1442-50. PubMed ID: 17881503
[TBL] [Abstract][Full Text] [Related]
40. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]